7.54
-0.38
(-4.80%)
At close: January 10 at 4:00:00 PM EST
7.54
0.00
(0.00%)
After hours: January 10 at 4:05:02 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BOYD RALPH F JR Director | Purchase | May 23, 2024 | 6,000 |
CHUPA ADDAM Chief Technology Officer | Conversion of Exercise of derivative security | Oct 31, 2024 | 63,110 |
DILORIO RICHARD Chief Executive Officer | Sale | Nov 27, 2024 | 416,659 |
EICHENBAUM KENNETH D Director | Purchase | Sep 23, 2024 | 4,000 |
FUNKE JEROD Officer | Conversion of Exercise of derivative security | Oct 9, 2024 | 10,831 |
GENDRON PAUL ANDREW Director | Purchase | May 20, 2024 | 65,000 |
HUSS BEVERLY A Director | Purchase | May 22, 2024 | 4,300 |
LACHANCE CARRIE President | Conversion of Exercise of derivative security | May 17, 2024 | 358,814 |
SHUDA SCOTT A Director | Conversion of Exercise of derivative security | May 14, 2024 | 442,618 |
STEELE BARRY G. Chief Financial Officer | Purchase | May 20, 2024 | 131,550 |
Related Tickers
NXGL NEXGEL, Inc.
3.3900
-1.17%
SMTI Sanara MedTech Inc.
32.23
-1.26%
EMBC Embecta Corp.
19.48
-3.80%
HBIO Harvard Bioscience, Inc.
1.9000
-11.63%
PDEX Pro-Dex, Inc.
46.97
-5.49%
LMAT LeMaitre Vascular, Inc.
93.59
-1.38%
HAE Haemonetics Corporation
76.67
-1.83%
ATRC AtriCure, Inc.
31.41
-6.68%
NVST Envista Holdings Corporation
18.58
-3.08%
RGEN Repligen Corporation
154.86
+0.10%